Furthermore, a previous study has also shown upregulation of PIGF in breast cancer patients, undergoing combination therapy of anthracyclines and trastuzumab, followed by sensitivity analysis which showed increased risk of developing cardiotoxicity with an increase in the level of PIGF (Putt et al., 2015). The gene discussed is PIGF; the disease is breast carcinoma.